Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL)Hisham Abdel‐Azim, Michael A. Pulsipher, Jemily Malvar et al.|Blood|2019Cited by 1
Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Event Free Survival (EFS) Irrespective of Hematopoietic Cell Transplantation (HCT) Conditioning Regimen, Graft Αβ T and B-Cell Depletion or Patient Weight Category in Children with Acute Lymphoblastic Leukemia (ALL)Hisham Abdel‐Azim, Michael A. Pulsipher, Christopher C. Dvorak et al.|Transplantation and Cellular Therapy|2020Cited by 1
High OS, PFS and EFS with Low Rates of Rejection and GVHD after KIR-Favorable abCD3/CD19 Depleted Haploidentical HCT in Children with ALL/AML/MDS: Primary Analysis of the Pediatric Transplantation and Cellular Therapy Consortium ONC1401 TrialHisham Abdel‐Azim, Mike A. Pulsipher, Christopher C. Dvorak et al.|Transplantation and Cellular Therapy|2021Cited by 0